The state of Indiana currently has 2 active clinical trials seeking participants for Primary Biliary Cholangitis research studies. These trials are conducted in various cities, including Indianapolis, South Bend, Fort Wayne and Evansville.
Open-Label Extension Study of Saroglitazar Magnesium in Participants with Primary Biliary Cholangitis
Recruiting
Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/29/2024
Locations: Zydus US001, Indianapolis, Indiana
Conditions: Primary Biliary Cholangitis
A Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis With Compensated Cirrhosis and Without Cirrhosis.
Recruiting
A Trial to Investigate the Pharmacokinetics (PK) Effects and Safety Profile of K-808 (Pemafibrate) in Primary Biliary Cholangitis (PBC) Subjects with and without Cirrhosis.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/26/2024
Locations: Indiana University School of Medicine - Indianapolis, Indianapolis, Indiana
Conditions: Primary Biliary Cholangitis, Compensated Cirrhosis